| Closed |
SWOG-9313 |
Phase III Comparison of Adjuvant Chemotherapy with High-Dose Cyclophosphamide plus Doxorubicin (AC) versus Sequential Doxorubicin followed by Cyclophosphamide (A’C) in High-Risk Breast Cancer… |
3/15/1994 |
5/1/1997 |
98% |
|
Published
|
| Closed |
SWOG-9312 |
Local Bladder |
10/1/1993 |
4/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9308 |
Randomized Trial Comparing Cisplatin With Cisplatin Plus Intravenous Navelbine® in the Treatment of Previously Untreated, Stage IV Non-Small Cell Lung Cancer Patients |
10/15/1993 |
6/1/1995 |
98% |
|
Published
|
| Closed |
SWOG-9307 |
Extended Administration of Oral Etoposide And Oral Cyclophosphamide for the Treatment of Poor Prognosis Extensive Disease Small Cell Lung Cancer, Phase II Pilot |
7/1/1993 |
6/1/1996 |
100% |
|
Published
|
| Closed |
SWOG-9305 (CALGB-8984) |
Evaluation of Topotecan in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II |
1/15/1994 |
5/15/1995 |
75% |
|
Published
|
| Closed |
SWOG-9304 (INT-0144) |
RECTAL |
3/1/1994 |
8/1/2000 |
98% |
|
Published
|
| Closed |
SWOG-9300 |
ATRA/IFN vs ATRA/HU for New CML |
10/1/1993 |
12/1/1999 |
95% |
|
|
| Closed |
SWOG-9249 |
Intensive Carboplatin/Cyclophosphamide/G-CSF Therapy Followed by Either Standard Dose Paclitaxel (Taxol®) or Intensive Paclitaxel (Taxol®)/G-CSF for Patients with Stage III Suboptimal Disease Ovarian… |
3/15/1995 |
7/1/1998 |
18% |
|
|
| Closed |
SWOG-9248 |
A Phase II Trial of Paclitaxel (Taxol ®) in Patients with Metastatic Refractory Carcinoma of the Breast |
6/1/1993 |
2/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9246 |
A Phase II Evaluation of Taxol in Patients with Relapsed Non-Hodgkin's Lymphoma |
3/1/1993 |
12/1/1995 |
58% |
|
Published
|
| Closed |
SWOG-9245 |
ANCILLARY: Central Lymphoma Tissue Repository for Relapsed or Recurrent Disease |
3/15/1993 |
|
|
|
|
| Closed |
SWOG-9242 |
Evaluation of Taxotere in Small Cell Lung Carcinoma, Phase II |
5/1/1993 |
1/15/1997 |
94% |
|
Published
|
| Closed |
SWOG-9241 |
Evaluation of Topotecan in Colorectal Cancer, Phase II |
7/15/1993 |
11/15/1994 |
100% |
|
Published
|
| Closed |
SWOG-9240 |
A Phase II Trial of CVAD for Treatment of Non-Hodgkin's Lymphoma |
1/15/1993 |
2/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9239 |
Post-Organ Transplant Lymphoproliferation Treatment |
4/15/1995 |
8/15/2000 |
40% |
|
Published
|
| Closed |
SWOG-9237 |
Topotecan in Resistant and Relapsing MM |
3/1/1993 |
2/15/1995 |
100% |
|
Published
|
| Closed |
SWOG-9235 |
Phase II Trial of Casodex in Advanced Prostate Cancer Patients Who Failed Conventional Hormonal Manipulation |
12/15/1993 |
6/1/1994 |
96% |
|
Published
|
| Closed |
SWOG-9230 |
Renal |
6/1/1993 |
5/1/1995 |
100% |
|
Published
|
| Closed |
SWOG-9229 |
Concurrent Cisplatin, Prolonged Oral Etoposide and Vincristine Plus Chest and Brain Irradiation for Limited Small Cell Lung Carcinoma, Phase II Pilot |
2/15/1993 |
5/1/1994 |
100% |
|
Published
|
| Closed |
SWOG-9228 |
Evaluation of Interleukin-4 (IL-4) in Disseminated Malignant Melanoma, Phase II |
3/1/1994 |
9/1/1995 |
90% |
|
Published
|
